Two genitourinary oncologists discussed research examining germline platelet polygenic risk scores to predict survival outcomes in kidney cancer.
Pablo Barrios, MD
Advertisement
Articles by Pablo Barrios, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
BCMA-Directed Bispecific Antibodies Navigating a New Era in Relapsed/Refractory Multiple Myeloma
2
Emerging Strategies in Prostate Cancer: Molecular Glues and T-Cell Engagers
3
NCCN Guidelines Add Novel Therapeutics to First-Line TNBC Armamentarium
4
FDA Approves Nivolumab/AVD in Untreated Hodgkin Lymphoma
5